Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 7
2003 8
2004 6
2005 9
2006 11
2007 14
2008 9
2009 10
2010 6
2011 11
2012 11
2013 7
2014 7
2015 6
2016 9
2017 7
2018 12
2019 9
2020 8
2021 10
2022 5
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

176 results

Results by year

Filters applied: . Clear all
Page 1
Targeting Glutamine Metabolism in Prostate Cancer.
Bhowmick N, Posadas E, Ellis L, Freedland SJ, Vizio DD, Freeman MR, Theodorescu D, Figlin R, Gong J. Bhowmick N, et al. Among authors: freeman mr. Front Biosci (Elite Ed). 2023 Jan 4;15(1):2. doi: 10.31083/j.fbe1501002. Front Biosci (Elite Ed). 2023. PMID: 36959101 Free article. Review.
Cholesterol and prostate cancer.
Pelton K, Freeman MR, Solomon KR. Pelton K, et al. Among authors: freeman mr. Curr Opin Pharmacol. 2012 Dec;12(6):751-9. doi: 10.1016/j.coph.2012.07.006. Epub 2012 Jul 21. Curr Opin Pharmacol. 2012. PMID: 22824430 Free PMC article. Review.
Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis.
Yan Y, Zhou B, Qian C, Vasquez A, Kamra M, Chatterjee A, Lee YJ, Yuan X, Ellis L, Di Vizio D, Posadas EM, Kyprianou N, Knudsen BS, Shah K, Murali R, Gertych A, You S, Freeman MR, Yang W. Yan Y, et al. Among authors: freeman mr. Nat Commun. 2022 Feb 3;13(1):669. doi: 10.1038/s41467-022-28340-6. Nat Commun. 2022. PMID: 35115556 Free PMC article.
Genetic and biological drivers of prostate cancer disparities in Black men.
Gong J, Kim DM, Freeman MR, Kim H, Ellis L, Smith B, Theodorescu D, Posadas E, Figlin R, Bhowmick N, Freedland SJ. Gong J, et al. Among authors: freeman mr. Nat Rev Urol. 2024 May;21(5):274-289. doi: 10.1038/s41585-023-00828-w. Epub 2023 Nov 14. Nat Rev Urol. 2024. PMID: 37964070 Review.
Caveolin-1 and prostate cancer progression.
Freeman MR, Yang W, Di Vizio D. Freeman MR, et al. Adv Exp Med Biol. 2012;729:95-110. doi: 10.1007/978-1-4614-1222-9_7. Adv Exp Med Biol. 2012. PMID: 22411316 Review.
ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate Cancer.
Qian C, Yang Q, Rotinen M, Huang R, Kim H, Gallent B, Yan Y, Cadaneanu RM, Zhang B, Kaochar S, Freedland SJ, Posadas EM, Ellis L, Vizio DD, Morrissey C, Nelson PS, Brady L, Murali R, Campbell MJ, Yang W, Knudsen BS, Mostaghel EA, Ye H, Garraway IP, You S, Freeman MR. Qian C, et al. Among authors: freeman mr. bioRxiv [Preprint]. 2023 Oct 12:2023.09.28.560025. doi: 10.1101/2023.09.28.560025. bioRxiv. 2023. PMID: 37905039 Free PMC article. Preprint.
Cholesterol and benign prostate disease.
Freeman MR, Solomon KR. Freeman MR, et al. Differentiation. 2011 Nov-Dec;82(4-5):244-52. doi: 10.1016/j.diff.2011.04.005. Epub 2011 Aug 20. Differentiation. 2011. PMID: 21862201 Free PMC article. Review.
176 results